🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy and safety of Sintilimab in Combination With S-1/o...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-03-01
Trial ID
NCT06046963
The purpose of this prospective, single-center, phase II study is to evalua...
Status
Recruiting
Location
Samsung Medical Center
Start Date
2026-05-15
Trial ID
NCT07607119
Treatments Being Tested
This clinical study is a Phase 2, open-label study to assess the efficacy, ...
Status
Completed
Location
Hanllym University Medical Center
Start Date
2021-05-18
Trial ID
NCT04768686
Treatments Being Tested
This study is a prospective, dual arm, open Ib/II phase clinical trial, wit...
Status
Not Yet Recruiting
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Start Date
2024-09-30
Trial ID
NCT06592287
Treatments Being Tested
The goal of this clinical trial is to learn if radical surgery improves pro...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2026-10-01
Trial ID
NCT07789184
This is a study in adults with various types of advanced cancer. The purpos...
Status
Completed
Location
University of California San Diego
Start Date
2019-03-19
Trial ID
NCT03697304
Treatments Being Tested
This is a multicenter Phase 1b, open-label study to assess safety, tolerabi...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #53
Start Date
2017-09-05
Trial ID
NCT03170960
Treatments Being Tested
This study uses to suppress the growth of tumors, extend the patient's surv...
Status
Unknown
Location
Multiple Locations
Start Date
2018-05-01
Trial ID
NCT03511703
Treatments Being Tested
This is an open, single arm, multicenter phase 2 trial in which BO-112 will...
Status
Terminated
Location
Institut Jules Bordet
Start Date
2020-06-17
Trial ID
NCT04508140
Treatments Being Tested
This Phase 1/2, multicenter, first-in-human, open-label, dose-escalation, d...
Status
Unknown
Location
Blacktown Hospital
Start Date
2022-05-03
Trial ID
NCT05102214
Treatments Being Tested